InnoPharma Overview

  • Founded
  • 2005
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 87
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $360M
Latest Deal Amount

InnoPharma General Information

Description

Developer of complex generic and innovative specialty pharmaceutical/bio-pharmaceutical products in injectable and ophthalmic dosage forms. The company has a broad portfolio of products under development, with formulations including, suspension, lyophilized, emulsions, liposomes, micelles and lipid complexes.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Parent Company
Primary Office
  • 10 Knightsbridge Road
  • Piscataway Township, NJ 08854
  • United States
+1 (732) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

InnoPharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 24-Sep-2014 $360M 0000 00000 Completed Product Development
3. Debt - General 13-Nov-2013 0000 0000 Completed Product Development
2. Debt - General 07-Jun-2012 $8M $23M Completed Product Development
1. Early Stage VC (Series A) 01-Dec-2011 $15M $15M 000.00 Completed Product Development
To view InnoPharma’s complete valuation and funding history, request access »

InnoPharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.00 00.00 00.00 00 00.00 00.000
Series A1 0,000,000 00 00 00 00 0.000
To view InnoPharma’s complete cap table history, request access »

InnoPharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of complex generic and innovative specialty pharmaceutical/bio-pharmaceutical products in injectable and ophth
Pharmaceuticals
Piscataway Township, NJ
87 As of 2014
0000
0000 0000-00-00
000000&0 0000

00000 00

labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris ni
000000000000000
Franklin Township, NJ
000 As of 0000
0000 0000-00-00
000000&0

0000 000

mco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volup
000000000000000
Monmouth Junction, NJ
000 As of 0000
000000000 -
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

InnoPharma Competitors (17)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Gavis Pharmaceuticals Corporate Backed or Acquired Franklin Township, NJ 000 000000&0
0000 000000 Private Debt Financed Monmouth Junction, NJ 000 000000000 -
0000000 00000 Private Equity-Backed Morristown, NJ 000 00000 000000000000 00000
00000000000 000000 Private Equity-Backed Mexico City, Mexico 000.00 0000000 0000
00000 ( 0000000000 Failed Transaction (M&A) Hafnarfjordur, Iceland 000 000000000000
You’re viewing 5 of 17 competitors. Get the full list »

InnoPharma Patents

InnoPharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200330411-A1 Process of manufacturing a stable, ready to use infusion bag for an oxidation sensitive formulation Pending 05-Feb-2016 0000000000
US-20190029979-A1 Process of manufacturing a stable, ready to use infusion bag for an oxidation sensitive formulation Abandoned 05-Feb-2016 0000000000 0
AU-2017215419-B2 Process of manufacturing a stable, ready to use infusion bag for an oxidation sensitive formulation Active 05-Feb-2016 0000000000 0
AU-2017215419-A1 Process of manufacturing a stable, ready to use infusion bag for an oxidation sensitive formulation Granted 05-Feb-2016 0000000000
AU-2019257508-A1 Process of manufacturing a stable, ready to use infusion bag for an oxidation sensitive formulation Granted 05-Feb-2016 A61K31/167
To view InnoPharma’s complete patent history, request access »

InnoPharma Executive Team (5)

Name Title Board Seat Contact Info
Navneet Puri Ph.D Chief Executive Officer, Board Member, Co-Founder & President
Sriram Ramanathan Chief Operating Officer & Co-Founder
You’re viewing 2 of 5 executive team members. Get the full list »

InnoPharma Board Members (4)

Name Representing Role Since
Peter Werth Self Board Member 000 0000
Raman Kapur Self Board Member 000 0000
You’re viewing 2 of 4 board members. Get the full list »

InnoPharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InnoPharma Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Athyrium Capital Management Asset Manager Minority 000 0000 000000 0
Thomas McNerney & Partners Venture Capital Minority 000 0000 000000 0
To view InnoPharma’s complete investors history, request access »